Shri Sachchita Dwarika Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.65 M
About Shri Sachchita Dwarika Pharmacy
Shri Sachchita Dwarika Pharmacy Private Limited (SSDPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 August 2020 (Four years and six months 15 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.65 M.
Abhishek Singh and Suman Singh serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85120UP2020PTC132639
- Company No.
132639
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Shri Sachchita Dwarika Pharmacy?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Singh  | Director | 13-Aug-2020 | Current |
| Suman Singh | Director | 25-Jan-2021 | Current |
Financial Performance of Shri Sachchita Dwarika Pharmacy.
Shri Sachchita Dwarika Pharmacy Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shri Sachchita Dwarika Pharmacy?
In 2021, Shri Sachchita Dwarika Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹1.65 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Apr 2022 | Indian Overseas Bank | ₹0.15 M | Open |
| 02 Mar 2021 | Indian Overseas Bank | ₹1.50 M | Open |
How Many Employees Work at Shri Sachchita Dwarika Pharmacy?
Shri Sachchita Dwarika Pharmacy has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shri Sachchita Dwarika Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Sachchita Dwarika Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
